1. Home
  2. MRNA vs LTM Comparison

MRNA vs LTM Comparison

Compare MRNA & LTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRNA
  • LTM
  • Stock Information
  • Founded
  • MRNA 2010
  • LTM 1929
  • Country
  • MRNA United States
  • LTM Chile
  • Employees
  • MRNA N/A
  • LTM N/A
  • Industry
  • MRNA Biotechnology: Biological Products (No Diagnostic Substances)
  • LTM
  • Sector
  • MRNA Health Care
  • LTM
  • Exchange
  • MRNA Nasdaq
  • LTM NYSE
  • Market Cap
  • MRNA 13.4B
  • LTM 12.6B
  • IPO Year
  • MRNA 2018
  • LTM N/A
  • Fundamental
  • Price
  • MRNA $34.15
  • LTM $41.91
  • Analyst Decision
  • MRNA Hold
  • LTM Strong Buy
  • Analyst Count
  • MRNA 20
  • LTM 3
  • Target Price
  • MRNA $46.76
  • LTM $38.00
  • AVG Volume (30 Days)
  • MRNA 9.4M
  • LTM 422.5K
  • Earning Date
  • MRNA 08-01-2025
  • LTM 01-01-0001
  • Dividend Yield
  • MRNA N/A
  • LTM 1.52%
  • EPS Growth
  • MRNA N/A
  • LTM 49.49
  • EPS
  • MRNA N/A
  • LTM 0.00
  • Revenue
  • MRNA $3,177,000,000.00
  • LTM $12,914,322,000.00
  • Revenue This Year
  • MRNA N/A
  • LTM $8.51
  • Revenue Next Year
  • MRNA $9.70
  • LTM $4.63
  • P/E Ratio
  • MRNA N/A
  • LTM $11.85
  • Revenue Growth
  • MRNA N/A
  • LTM 6.41
  • 52 Week Low
  • MRNA $23.15
  • LTM $21.83
  • 52 Week High
  • MRNA $125.68
  • LTM $43.07
  • Technical
  • Relative Strength Index (RSI)
  • MRNA 64.57
  • LTM N/A
  • Support Level
  • MRNA $30.88
  • LTM N/A
  • Resistance Level
  • MRNA $35.59
  • LTM N/A
  • Average True Range (ATR)
  • MRNA 1.48
  • LTM 0.00
  • MACD
  • MRNA 0.11
  • LTM 0.00
  • Stochastic Oscillator
  • MRNA 74.05
  • LTM 0.00

About MRNA Moderna Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

About LTM LATAM AIRLINES GROUP SA SPON ADS EACH REP 2000 SHS

LATAM Airlines Group SA operates as a passenger airline group. The company and its affiliates provide domestic services in Brazil, Chile, Peru, Colombia, and Ecuador, as well as regional flights and long-haul operations. LATAM group carries out cargo operations using both belly space on passenger flights and dedicated freighter aircraft. In addition, it also offers complementary services, such as ground handling, courier, logistics, and maintenance. Geographically, the group generates maximum revenue from Brazil, followed by Chile, the United States of America, Peru, Europe, Colombia, Ecuador, Asia Pacific, and the rest of Latin America.

Share on Social Networks: